Search

everythinglearnresearchcommunity

for

Search:↓

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Resolving malaria-related lung issues doesn't rely on Alox12 and leaves some inflammation.

Targeting CXCL10 may help treat alopecia areata.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Melatonin may help reduce the needed dose of prednisolone and improve hair growth in alopecia areata patients.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

Washing can prevent cancer from lubricating oils, extreme body temperatures need more study, Sulfomid is not recognized, no reliable diphtheria carrier treatment except surgery, eyelid injuries should heal before repair, heterophile antibody test is specific for mononucleosis, chlorine inhalations for colds are outdated, and wheat germ is safe.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Lack of Vitamin D receptor changes skin structure and increases certain immune cells in the skin.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

Lysophospholipids can act as anti-inflammatory agents through specific receptors, but more research is needed.

CS12192 effectively treats alopecia areata with better safety than current options.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Certain genetic variations can make people more likely to experience hair loss and low white blood cell count from azathioprine.

The combination therapy was effective and well-tolerated, especially in young patients.

Hydroxytyrosol helps reduce liver injury by blocking certain inflammation pathways.

Interferon therapy improves quality of life for chronic hepatitis B patients.

A woman's long-term scalp issues were diagnosed as a rare skin disorder called cutaneous Langerhans cell histiocytosis.

Bullous lupus can cause severe esophageal issues but responds well to corticosteroids and azathioprine.

A woman experienced hair loss, nail changes, bone marrow suppression, and low blood protein after taking azathioprine.

Stopping azathioprine led to full hair regrowth and recovery in 2.5 months.

All-trans retinoic acid helps amelanotic melanocytes in hair follicles develop and produce pigment while reducing their growth.